The project, called the Southeast Genomic Medicine Service, or SE-GEMS, will create a genomic eConsult service that allows clinicians to ask practical questions about genetic testing, test interpretation and next steps in care.

Genetic variants known to slow or speed metabolism of drugs for depression and anxiety disorders are very common.

A multi-institutional group has identified a “signature” of metabolic molecules associated with exercise-induced physiologic deficits that, when released into the bloodstream, signal heightened heart failure risk.

These findings highlight the critical need for tumor genomic testing for all patients to identify those with high-risk tumors, which occur more frequently in Black women, and which require more aggressive treatment to prevent recurrence.

Using Fitbits, researchers set out to discover how many additional steps patients need to reduce risks of chronic disease.

Dataset grows to more than 312,000 whole genomes with longitudinal clinical data. GSK is one of the first to lead a further expansion of 50,000 whole genomes paired with proteomic data.

While diltiazem remains an effective option for heart rate control in selected patients, bleeding risk posed by anticoagulants should be considered.